Mechanistically, we revealed that FTO protects CRC from ferroptotic cell death, not only by increasing the expression of SLC7A11, but also increasing antioxidant capacity, accumulation of lipid ROS, and ultimately the occurrence of oxidative damage and ferroptosis by enhancing the GPX4 activity. This evidence concerns the gene SLC7A11 and colorectal carcinoma.